elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37745916-3667CE35-D914-45B5-8D21-D31514A12EE6
Q37745916-3667CE35-D914-45B5-8D21-D31514A12EE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37745916-3667CE35-D914-45B5-8D21-D31514A12EE6
Pathological complete response of HER2-positive breast cancer to trastuzumab and chemotherapy can be predicted by HSD17B4 methylation
P2860
Q37745916-3667CE35-D914-45B5-8D21-D31514A12EE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37745916-3667CE35-D914-45B5-8D21-D31514A12EE6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0a862c4f8eb618d38d290f136b5fdded272b6b63
P2860
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial.